| Annual Financials | 2020 | 2021 | 2022 | TTM |
Revenue  | 216 | 249 | 342 | 0 |
| Expenses | 176 | 194 | 264 | 0 |
| EBITDA | 40 | 55 | 79 | 0 |
| Operating Profit % | 17 % | 20 % | 22 % | 0 % |
| Depreciation | 11 | 13 | 14 | 0 |
| Interest | 14 | 14 | 11 | 0 |
| Profit Before Tax | 15 | 29 | 54 | 0 |
| Tax | 4 | 8 | 12 | 0 |
| Net Profit | 11 | 21 | 42 | 0 |
| EPS in ₹ | 4.11 | 7.92 | 5.22 | 0.00 |
GPT Healthcare
GPT Healthcare
143.33
-0.01
(-0.01%)
Market Cap
₹1,176.09 Cr
PE Ratio
25.82
Volume
23,153.00
Day High - Low
₹143.99 - ₹142.20
52W High-Low
₹192.00 - ₹126.10
Key Fundamentals
Market Cap
1,176.09 Cr
EPS
5.22
PB Ratio
5.96
Book Value
24.15
EBITDA
78.80
Dividend Yield
2.67 %
Industry
Healthcare Services Sector
Hospitals ROE Growth %
-
Debt to Equity
0.76
Analyst Rating and Forecast
- By Refinitiv from1 analysts
Actual
Company News
View All News
GPT Healthcare Reports 12.5% Revenue Growth to INR 118.9 Crores in Q2 FY26, EBITDA Margin at 20%
Nov 14, 2025
Nov 14, 2025GPT Healthcare achieved revenue growth of 12.5% year-on-year to INR 118.9 crores with profit after tax of INR 10.6 crores, though EBITDA dropped 10% due to initial losses from new Raipur hospital operations. The company signed an MOU for a 150-bed hospital in Jamshedpur with INR 70 crores investment and targets becoming a 1,000-bed hospital chain over the next two years.
GPT Healthcare Limited reported total income of Rs 228.92 crore for H1FY26, representing a 9.8% increase from Rs 208.5 crore in H1FY25. Revenue from operations grew 11% to Rs 226 crore. However, net profit declined 26.2% to Rs 18.3 crore from Rs 24.7 crore in the previous year. EBITDA margin compressed to 18.8% from 22.2% in H1FY25. The company operates 719 beds across five multispecialty hospitals in Eastern India with an overall bed occupancy rate of 44.7%. Average revenue per occupied bed stood at Rs 38,376. The company recently commissioned a new 158-bed hospital in Raipur in May 2025 and declared an interim dividend of Re 1 per share. GPT Healthcare targets becoming a 1,000-bed facility within the next two years, focusing on Tier I and Tier II cities in Eastern India.
GPT Healthcare's board recommended an interim dividend of 1 rupee per share. The company reported Q2 net profit of 106 million rupees, down from 148 million rupees in the same period last year. Revenue increased to 1.19 billion rupees from 1.05 billion rupees year-over-year. EBITDA declined to 227.4 million rupees from 234.2 million rupees, with EBITDA margin falling to 19.13% from 22.17% in the previous year.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,166.20 | #1 1,13,382.21 | 83.67 | 7,184.10 | #1 28.65 | 1,076 | #1 74.34 | 53.89 | |
7,343.00 | 1,05,581.07 | 61.72 | #1 21,994.30 | 14.76 | #1 1,505 | 24.84 | 35.14 | |
911.30 | 68,799.34 | 68.04 | 7,849.70 | 13.25 | 809 | 70.27 | 34.06 | |
1,949.70 | 39,844.23 | 48.80 | 5,575.00 | 12.29 | 790 | 30.03 | 58.50 | |
659.80 | 34,185.63 | 94.45 | 4,286.70 | 15.12 | 337 | 14.65 | 45.93 | |
1,244.80 | 33,459.03 | 58.06 | 3,771.40 | 12.59 | 481 | 21.10 | 48.05 | |
681.05 | 27,251.46 | 75.73 | 3,067.00 | 21.98 | 415 | -40.35 | 45.74 | |
535.90 | 16,942.93 | 107.45 | 1,757.00 | 27.64 | 110 | 71.36 | 58.70 | |
5,985.00 | 15,273.23 | #1 28.77 | 599.90 | 11.69 | 58 | 16.17 | 35.32 | |
1,351.60 | 13,726.74 | 53.31 | 1,566.90 | 17.46 | 244 | -4.30 | 51.13 |
Growth Rate
Revenue Growth
37.57 %
Net Income Growth
97.63 %
Cash Flow Change
53.50 %
ROE
67.13 %
ROCE
54.46 %
EBITDA Margin (Avg.)
3.97 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 |
| Total Assets | 309 | 317 | 323 |
| Fixed Assets | 226 | 220 | 220 |
| Current Assets | 63 | 86 | 86 |
| Capital Work in Progress | 2 | 0 | 1 |
| Investments | 1 | 1 | 10 |
| Other Assets | 80 | 97 | 92 |
| Total Liabilities | 309 | 317 | 323 |
| Current Liabilities | 65 | 60 | 69 |
| Non Current Liabilities | 117 | 123 | 97 |
| Total Equity | 127 | 134 | 158 |
| Reserve & Surplus | 69 | 76 | 78 |
| Share Capital | 18 | 18 | 80 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 |
| Net Cash Flow | -1 | 4 | 4 |
| Investing Activities | -54 | -17 | -5 |
| Operating Activities | 42 | 43 | 66 |
| Financing Activities | 12 | -22 | -57 |
Share Holding
| % Holding | Oct 2021 | Oct 2023 | Feb 2024 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 99.97 % | 67.34 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % | 65.57 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 6.68 % | 5.38 % | 4.70 % | 4.72 % | 4.48 % | 4.96 % | 3.20 % |
| DIIs | 0.00 % | 0.00 % | 10.07 % | 12.81 % | 13.08 % | 11.99 % | 11.30 % | 11.35 % | 9.32 % | 6.46 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 17.14 % | 12.16 % | 13.61 % | 15.07 % | 15.33 % | 15.55 % | 16.65 % | 18.89 % |
| Others | 0.03 % | 32.66 % | 7.22 % | 2.78 % | 2.35 % | 2.66 % | 3.08 % | 3.04 % | 3.50 % | 5.87 % |
| No of Share Holders | 9 | 9 | 9 | 76,664 | 71,293 | 74,737 | 70,147 | 68,365 | 67,060 | 67,617 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5 | 3.5 | 2.5 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.84 | 2.38 | 1.74 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 02 Apr 2024 |  Dividend | ₹ 1.00 /share | 02 Apr 2024 | 167.25 | 177.30 |
| 18 Jul 2024 | Dividend | ₹ 1.50 /share | 18 Jul 2024 | 162.50 | 170.95 |
| 25 Jul 2024 |  Annual General Meeting | NA | 25 Jul 2024 | 162.50 | 167.99 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 173.64 | 163.54 |
| 28 Nov 2024 | Dividend | ₹ 1.00 /share | 28 Nov 2024 | 163.54 | 173.98 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 178.93 | 161.60 |
| 23 May 2025 | Quarterly Result Announcement | NA | 23 May 2025 | 156.88 | 155.00 |
| 29 Jul 2025 | Dividend | ₹ 1.50 /share | 29 Jul 2025 | 155.00 | 159.63 |
| 05 Aug 2025 | Annual General Meeting | NA | 05 Aug 2025 | 155.00 | 183.40 |
| 06 Aug 2025 | Quarterly Result Announcement | NA | 06 Aug 2025 | 161.35 | 180.01 |
| 08 Nov 2025 | Quarterly Result Announcement | NA | 08 Nov 2025 | 149.82 | 147.35 |
| 14 Nov 2025 | Dividend | ₹ 1.00 /share | 14 Nov 2025 | 147.35 | 143.45 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 11, 2025
Nov 11, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 10, 2025
Nov 10, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 08, 2025
Nov 08, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 08, 2025
Nov 08, 2025Results-Unaudited Financial Results For The 2Nd Quarter And Half Year Ended September 30 2025.Nov 08, 2025
Nov 08, 2025Corporate Action- Board Fixes Record Date For Interim DividendNov 08, 2025
Nov 08, 2025Corporate Action-Board approves DividendNov 08, 2025
Nov 08, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On November 8 2025Nov 08, 2025
Nov 08, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 04, 2025
Nov 04, 2025Board Meeting Intimation for Considering Inter Alia And Approving The Unaudited Financial Results Of The Company For The 2Nd Quarter And Half Year Ended On September 30 2025 And To Declare Interim Dividend For The Financial Year 2025-26.Oct 31, 2025
Oct 31, 2025Appointment (Regularization) Of Mr. Shree Gopal Tantia Promoter (DIN:00001346) As Non-Executive Director Of The CompanyOct 29, 2025
Oct 29, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationOct 29, 2025
Oct 29, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportOct 29, 2025
Oct 29, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotOct 29, 2025
Oct 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 15, 2025
Oct 15, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 14, 2025
Oct 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 27, 2025
Sep 27, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Intimation Regarding 100 Days Campaign-Saksham NiveshakSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateSep 24, 2025
Sep 24, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On September 24 2025Sep 24, 2025
Sep 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 09, 2025
Sep 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 30, 2025
Aug 30, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateAug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 09, 2025
Aug 09, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 06, 2025
Aug 06, 2025Results- Unaudited Financial Results For The 1St Quarter Ended June 30 2025.Aug 06, 2025
Aug 06, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On August 6 2025Aug 06, 2025
Aug 06, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 28, 2025
Jul 28, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Along With Limited Review Report Of The Statutory Auditors Thereon Of The Company For The 1St Quarter Ended June 30 2025.Jul 28, 2025
Jul 28, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Jul 15, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 14, 2025
Jul 14, 2025Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The CompanyJul 12, 2025
Jul 12, 202536Th Annual General Meeting To Be Held On Tuesday August 5 2025Jul 12, 2025
Jul 12, 2025Reg. 34 (1) Annual Report.Jul 12, 2025
Jul 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 07, 2025
Jul 07, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
May 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 24, 2025
May 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 24, 2025
May 24, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan Small Cap Fund Direct-Growth | 0.28% | 157855 | -0.01% | 0.14% | |
| Bandhan Infrastructure Fund Direct Plan-Growth | 0.56% | -127705 | -0.12% | -0.12% | |
| Bandhan BSE Healthcare Index Fund Direct-Growth | 0.03% | 2 | 0.00% | 0.00% | |
 Axis Balanced Advantage Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
| Axis Multi Asset Allocation Direct Plan -Growth | 0.00% | 0 | 0.00% | -0.03% | |
| Axis Value Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
| Bandhan Retirement Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 Kotak Equity Savings Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
| Kotak Multi Asset Allocation Fund Direct - Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 44.01
ATR(14)
Less Volatile 3.46
STOCH(9,6)
Neutral 26.04
STOCH RSI(14)
Neutral 42.99
MACD(12,26)
Bearish -0.09
ADX(14)
Weak Trend 14.40
UO(9)
Bearish 37.12
ROC(12)
Uptrend And Accelerating 0.45
WillR(14)
Neutral -63.24
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
